December 2011, I attended the POLCYB meeting in Los Angeles. A major pharmaceutical manufacturer attended. The pharmaceutical representative mentioned they had not addressed ICS cyber security as they had simply not considered it and there was no regulatory driver.
April 11th, 2013, I attended the San Francisco Electronic Crimes Task Force Medical Device Security Conference ( see previous blog on the meeting). If they didn't continue to repeat the words "medical device", the conference could have been an electric, water, chemical, mass transit, manufacturing, etc ICS cyber security conference. The discussions and presentations demonstrated the medical device community was generally in denial, or unaware, about ICS cyber security.
May 10th, 2013, I had a discussion with a representative from a small pharmaceutical company. When I mentioned cyber security, he said it didn't affect them as they were small and their systems were isolated. When we talked further, he stated that a small company on the other side of the country had access to the programmable logic controller (PLC) controlling their manufacturing process. He went on to say that their contractual documents only addressed confidentiality not security and there was no regulatory driver to look further.
Even though these are anecdotal, it appears many in the medical device and pharmaceutical industries do not understand and are not addressing ICS cyber security.